/TBP.TO
TBP.TO Stock - Tetra Bio-Pharma Inc.
Healthcare|BiotechnologyTSX
$0.03+0.00%
+$0.00 (+0.00%) • Mar 6
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.30
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.28
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.03
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TBP.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.03
TARGET (TP)$0.03
STOP LOSS$0.02
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.29
52W High$0.07
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $112,320 | N/A |
| Gross Profit | N/A | N/A | N/A | $44,729 | N/A |
| Gross Margin | N/A | N/A | N/A | 39.8% | N/A |
| Operating Income | $-24,841,290 | $-19,941,094 | $-13,386,171 | $-11,584,207 | $-6,396,776 |
| Net Income | $-53,419,412 | $-26,899,115 | $-15,668,131 | $-7,572,555 | $-6,225,294 |
| Net Margin | N/A | N/A | N/A | -6741.9% | N/A |
| EPS | $-0.12 | $-0.10 | $-0.08 | $-0.05 | $-0.06 |
Company Overview
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TBP.TOBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2022
EPS Surprise History
Q1 21
No data
Q2 21
No data
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Nov 3, 2023 | — | — | — | — |
Q3 2023 | Aug 25, 2023 | — | — | — | — |
Q2 2023 | May 26, 2023 | — | — | — | — |
Q2 2023 | Apr 26, 2023 | — | — | — | — |
Q4 2022 | Oct 16, 2022 | — | $-0.01 | — | — |
Q3 2022 | Jul 14, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 13, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.08 | — | — |
Q4 2021 | Oct 13, 2021 | — | $-0.01 | — | — |
Q3 2021 | Jul 14, 2021 | — | $-0.02 | — | — |
Q2 2021 | Apr 13, 2021 | — | $-0.03 | — | — |
Q1 2021 | Feb 17, 2021 | — | $-0.02 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.04 | — | — |
Q3 2020 | Jul 20, 2020 | — | $-0.02 | — | — |
Q2 2020 | Apr 28, 2020 | — | $-0.02 | — | — |
Q1 2020 | Mar 25, 2020 | — | $-0.02 | — | — |
Q4 2019 | Oct 18, 2019 | — | $-0.02 | — | — |
Q3 2019 | Jul 25, 2019 | — | $-0.02 | — | — |
Q2 2019 | Apr 26, 2019 | — | $-0.02 | — | — |
Q1 2019 | Mar 15, 2019 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about TBP.TO
What is TBP.TO's current stock price?
Tetra Bio-Pharma Inc. (TBP.TO) is currently trading at $0.03 per share. The stock has moved +0.00% today.
What is the analyst price target for TBP.TO?
No analyst price targets are currently available for this stock.
What sector is Tetra Bio-Pharma Inc. in?
Tetra Bio-Pharma Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the TSX exchange.
What is TBP.TO's market cap?
Tetra Bio-Pharma Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does TBP.TO pay dividends?
No, Tetra Bio-Pharma Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAH.TO
Aleafia Health Inc.
$0.02
Mkt Cap: $0.0B
CDX.V
Cloud DX Inc.
$0.13
Mkt Cap: $0.0B
CNFA.CN
CanaFarma Hemp Products Corp.
$0.05
Mkt Cap: $0.0B
COOL.CN
Core One Labs Inc.
$0.14
Mkt Cap: $0.0B
DOC.V
CloudMD Software & Services Inc.
$0.04
Mkt Cap: $0.0B
IMV.TO
IMV Inc.
$1.12
Mkt Cap: $0.0B
KHRN.V
Khiron Life Sciences Corp.
$0.04
Mkt Cap: $0.0B
MCUR.CN
Mind Cure Health Inc.
$0.07
Mkt Cap: $0.0B
RYAH.CN
RYAH Group, Inc.
$0.03
Mkt Cap: $0.0B
VIVO.TO
VIVO Cannabis Inc.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to TBP.TO for comparison